EODData

FRA, 471A: aTyr Pharma Inc

02 Jul 2026
LAST:

0.4180

CHANGE:
 0.05
OPEN:
0.4180
HIGH:
0.4180
ASK:
0.0000
VOLUME:
0
CHG(%):
14.21
PREV:
0.3660
LOW:
0.4180
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
02 Jul 260.41800.41800.41800.41800
29 Jun 260.36600.36600.36600.36600
25 Jun 260.39400.39400.39400.39400
23 Jun 260.31000.31000.31000.31000
22 Jun 260.30800.30800.30800.30800
19 Jun 260.30800.30800.30800.30800
17 Jun 260.28500.28500.28500.28500

PROFILE

Name:aTyr Pharma Inc
About:aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; and in Phase 1b/2a clinical trial to treat other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical development for the treatment fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
Sector:Healthcare
Industry:Biotechnology
Address:10240 Sorrento Valley Road, San Diego, CA, United States, 92121
Website:https://atyrpharma.com
ISIN:US0021202025

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-0.51 
Forward P/E:-0.22 
PEG Ratio:0.01 
Price to Sales:236.36 
Price to Book:0.88 
Operating Margin:-385.74 
Return on Assets:-0.52 
Return on Equity:-1.06 
Revenue:166.6K 
Shares:97.99M 
Market Cap:40.96M 

TECHNICAL INDICATORS

MA5:0.3616.4%
MA10:0.3521.0%
MA20:0.420.0%
MA50:0.5838.0%
MA100:0.5736.3%
MA200:1.70307.2%
STO9:100.00 
STO14:100.00 
RSI14:34.62 
MTM14:0.17
ROC14:0.67 
ATR:0.06 
Week High:0.420.0%
Week Low:0.3714.2%
Month High:0.420.0%
Month Low:0.29307.2%
Year High:5.681,259.6%
Year Low:0.2566.5%
Volatility:244.11 

RECENT SPLITS

Date Ratio
01 Jul 20191-14